Log in

Login to your account

Username
Password *
Remember Me

PAD-IQ Logo 2013

  • Supports Non-Invasive Upper and Lower Extremity Vascular Assessments
    • Skin Perfusion Pressure – Microcirculation (segmental pressure assessments with reactive hyperemia)
    • Pulse Volume Recording (segmental volume plethysmography)
    • Ankle Brachial Index (ABI) Calculation for Doppler-obtained pressures

Vasamed Supports Telemedicine

SensiLase PAD-IQ can go wherever you treat patients; a ruggedized, customized roller bag keeps the product safe and has ample room for supplies. SensiLase PAD-IQ features access to the internet via Bluetooth, WiFi or Ethernet while Studycast permits you to log-in from anywhere to upload data and images for expert consult and secure data storage.

Read More

Are you using your “IQ” to test for PAD and CLI?

Väsamed’s SensiLase PAD-IQ System featuring Studycast Data Management offers health professionals numerous support tools for both PAD and CLI to enable noninvasive vascular diagnostics, data communication and management. Read more about tissue perfusion, reactive hyperemia, volume plethysmography and wound imaging here.

Read More

19302784

Who is at risk for P.A.D?

Patients over age 50 and who also have a history of diabetes or history of smoking are at risk of PAD. Even patients under age 50 but who have diabetes and risk factors such as obesity, high blood pressure, a history of non-healing ulcers, erectile dysfunction (ED) or kidney disease (CKD/ESRD) are at risk. Consult your doctor if you exhibit these risk-factors.

Read More

Latest News

  • UCSF 2015 Vascular Symposium
    Written by
    Pictured with PAD-IQ and Väsamed Regional Manager, Emily Fjerstad, at UCSF 2015 Vascular Symposium, are Dr. Michael Conte, Chief, Vascular & Endovascular Surgery, Co-Director, UCSF Heart and Vascular, and Medical Director, Vascular Noninvasive Laboratory and Dr. Michael Palmer.
    Written on Monday, 27 April 2015 15:13 in Vasamed News
  • Angiosome-Guided SPP testing at APWCA
    Written by
    John Campbell, Väsamed discussing PAD IQ and angiosome-guided SPP to predict wound healing with Dr. Thomas Serena, President APWCA, Jacinda DiPlacido, CRNP, VA-Erie PA and others at APWCA 2015. Working together to prevent amputations!
    Written on Wednesday, 01 April 2015 20:32 in Vasamed News
  • Consensus that Skin Perfusion Pressure (SPP) should be used as a hemodynamic definition for CLI.
    Written by
    Consensus that Skin Perfusion Pressure (SPP) should be used as a hemodynamic definition for CLI.   Members of the PARC , the U.S. Food and Drug Administration and the Japanese Pharmaceuticals and Medical Devices Agency worked together “to develop a series of pragmatic consensus definitions for patients being treated for…
    Written on Wednesday, 04 March 2015 22:37 in Vasamed News
  • Post-procedural Skin Perfusion Pressure Correlates With Clinical Outcomes 1 Year After Endovascular Therapy in Patients with Critical Limb Ischemia
    Written by
    Published online before print in ANGIOLOGY February 4, 2015 multicenter OLIVE registry of patients who received EVT for CLI assessed the association between clinical outcomes and postoperative SPP in 211 consecutive subjects. It was concluded that post EVT SPP assessments correlated with clinical outcomes (Amputation Free Survival, p = 0.018;…
    Written on Thursday, 26 February 2015 14:40 in Vasamed News
  • Michigan Podiatric Medical Association Meeting
    Written by
    On February 5th – 8th Väsamed attended the Michigan Podiatric Medical Association meeting in Dearborn, MI. The meeting was attended by approximately 325 podiatric specialists from Michigan. On February 6th the meeting included an entire morning symposium on Peripheral Arterial Disease (PAD). During this session both podiatry and peripheral arterial…
    Written on Monday, 09 February 2015 22:02 in Vasamed News

Upcoming Events